This is a clinical study to investigate the safety and efficacy of Synvisc and Depo-Medrol in treating patients with osteoarthritis (OA) of the hip.
Inclusion Criteria:
Exclusion Criteria:
Birmingham, Alabama 35235, United States
Huntsville, Alabama 35802, United States
Scottsdale, Arizona 85260, United States
Little Rock, Arkansas 72205, United States
Los Angeles, California 90048, United States
Oakland, California 94609, United States
San Diego, California 92123, United States
Clearwater, Florida 33756, United States
Miami, Florida 33133, United States
Columbus, Georgia 31909, United States
Meridian, Idaho 83642, United States
Chicago, Illinois 60611, United States
Morton Grove, Illinois 60053, United States
Cedar Rapids, Iowa 52403, United States
Leawood, Kansas 66211, United States
Lexington, Kentucky 40509, United States
Shreveport, Louisiana 71101, United States
Baltimore, Maryland 21201, United States
Flint, Michigan 48507, United States
St Louis, Missouri 63110, United States
New Brunswick, New Jersey 08901, United States
New York, New York 10021, United States
Oklahoma City, Oklahoma 73109, United States
Grants Pass, Oregon 97527, United States
Duncansville, Pennsylvania 16635, United States
Lancaster, Pennsylvania 17601, United States
Pittsburgh, Pennsylvania 15212, United States
Conway, South Carolina 29526, United States
Chattanooga, Tennessee 37404, United States
Lubbock, Texas 79410, United States
Vinton, Virginia 24179, United States
Seattle, Washington 98166-2967, United States